Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_assertion type Assertion NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_head.
- NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_assertion description "[40 (98%) hemangioblastomas expressed angptl4 whereas all pheochromocytomas (n = 23) and pancreatic tumors (n = 25) were angptl4-negative, whatever their VHL status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_provenance.
- NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_assertion evidence source_evidence_literature NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_provenance.
- NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_assertion SIO_000772 20454689 NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_provenance.
- NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_assertion wasDerivedFrom befree-20150227 NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_provenance.
- NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_assertion wasGeneratedBy ECO_0000203 NP901917.RAdSJnmjhyNPUSp5M2LcKc93SM9j2oU-IHqUr4r_fPT6s130_provenance.